COMMUNIQUÉS West-GlobeNewswire

Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase 2

08/01/2018 - 14:00

PLYMOUTH MEETING, Pa., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) announced today it has received a milestone payment from MedImmune as MEDI0457 (formerly called INO-3112 which [...]

XOMA Strengthens Leadership Team with Appointments of Chief Business Officer and General Counsel

08/01/2018 - 13:00

EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA ), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced the appointments of Dee Datta, Ph. [...]

IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year

08/01/2018 - 13:00

MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today provided preliminary operational and financial results for the fourth quarter and full year ended December 30, 2017. [...]

Kamada Announces Interim Results from Phase 2 Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection

08/01/2018 - 13:00

Kamada’s IV AAT Demonstrated Favorable Safety and Tolerability Profile in 10 Patients During First Six Months of Treatment, Consistent with Previously Observed Results in Other Indications Next Interim Report Expected [...]

Microbot Medical Enters into Agreement to Acquire Novel Technology to Enhance Existing Technology Platforms and Strengthen Patent Portfolio

08/01/2018 - 13:00

HINGHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer

08/01/2018 - 13:00

HOUSTON, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company’s clinical site investigator has initiated patient recruitment for the second dosing group for the Prolanta™ Phase [...]

Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Endpoints in Two Phase 2 Clinical Trials for Common Warts

08/01/2018 - 13:00

Highly statistically significant results on all primary and secondary endpoints Statistical significance seen as early as day 28, after 4 weeks of treatment in WART-203 If approved, A-101 45% would be the first FDA [...]

NeuroMetrix Reports Preliminary 2017 Financial Highlights

08/01/2018 - 13:00

WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported preliminary financial highlights for the fourth quarter and for the full year 2017. GAAP revenue for the fourth quarter [...]

Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance

08/01/2018 - 13:00

Company Issues Preliminary Fourth Quarter and Full Year 2017 Expectations In Conjunction with J.P. Morgan Healthcare Conference Participation Preliminary Fourth Quarter 2017 Expectations Fourth quarter revenue expected [...]

AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue

08/01/2018 - 13:00

Q4 Revenue will be at least $16.5 million, representing 45% growth over prior year 2017 Revenue will be at least $60.0 million, representing 46% growth over prior year ALACHUA, Fla., Jan. 08, 2018 (GLOBE NEWSWIRE) -- [...]

ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology

08/01/2018 - 13:00

LEIDEN, the Netherlands, Jan. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ: PRQR ), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext & NASDAQ: [...]

Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year

08/01/2018 - 13:00

DANVERS, Mass. and SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today reported preliminary, unaudited, third quarter [...]

Natus Medical Announces 2018 Annual and First Quarter Financial Guidance

08/01/2018 - 12:50

Announces Fourth Quarter preliminary revenue results Announces Fourth Quarter 2017 Financial Results Conference Call Date PLEASANTON, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) [...]

K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2017 Financial Results

08/01/2018 - 12:45

LEESBURG, Va., Jan. 08, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

ChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in Singapore

08/01/2018 - 12:30

IRVINE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN ™ [...]

Avivagen Announces Positive Results from Dairy Cattle Trial

08/01/2018 - 12:30

OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use [...]

Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results

08/01/2018 - 12:30

Preliminary Fourth Quarter Highlights: Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the company’s previous implied guidance range of $345 million to $355 [...]

Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook

08/01/2018 - 12:30

GAITHERSBURG, Md., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced preliminary unaudited 2017 financial results and guidance for 2018. Daniel J. Abdun-Nabi, president and chief [...]

US ARMY Fully Funds Spider Silk Development Contract with Kraig Biocraft Laboratories

08/01/2018 - 12:05

ANN ARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the US ARMY has fully funded its [...]